#USA #New York City #investor conference #Cannabis Products #Curaleaf

Curaleaf Announces Conference Participation

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), a premier provider of consumer and medical cannabis products, has officially confirmed its participation in an upcoming investor conference scheduled for September 9, 2026. The ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference will be held in New York City, where key members of Curaleaf's executive management team will represent the company.

Executive Team Participation

The conference will feature discussions led by Joe Lusardi, Executive Vice Chairman of Curaleaf, alongside Ed Kremer, the Chief Financial Officer, and Camilo Lyon, Chief Investment Officer. Their engagement aims to provide investors with insights into Curaleaf's operational strategies, market positioning, and growth initiatives within the increasingly competitive cannabis industry.

Details of the Conference

The ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference is a significant event in the financial calendar, bringing together leading companies and institutional investors. This year, Curaleaf is not just attending but actively participating in one-on-one investor meetings, which will allow for in-depth discussions about their financial performance and growth potential. The event highlights Curaleaf's commitment to fostering relationships with the investment community and sharing its vision for the future.

Curaleaf's Mission and Vision

Curaleaf's mission is clear: to enhance lives through the cultivation, sharing, and celebration of cannabis. As a leading player in the cannabis market, the company is well-regarded for its reliable, high-quality products and industry expertise. Curaleaf operates with a diverse range of brands, including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem, each tailored to meet the needs of both medical and adult-use consumers.

The company emphasizes quality and sustainability, utilizing a strong presence across various stages of the supply chain. This comprehensive approach positions Curaleaf favorably in a rapidly evolving market, including their operations across Europe, Canada, and Australasia.

Access and Information

For investors and interested parties wanting to learn more about Curaleaf’s participation in the conference and access potential webcasts, detailed information can be found on Curaleaf’s Investor Relations (IR) website at Curaleaf IR. This platform will provide updates regarding the conference and access to all relevant presentations and discussions.

Conclusion

As Curaleaf continues to navigate the complexities of the cannabis industry, its participation in the upcoming investor conference highlights the company's proactive approach to maintaining transparency and engagement with its stakeholders. The executive team's involvement at such significant financial events reflects their dedication to driving growth and creating value for shareholders while reinforcing Curaleaf's position as a leader in the cannabis sector.